|
Volumn 6, Issue 10, 1995, Pages 1011-1017
|
Sequential biochemotherapy for metastatic colorectal cancer using fluorouracil, folinic acid, thymopentin and interleukin-2: Clinical and immunological effects
a a a a a a a b c c |
Author keywords
Advanced colorectal cancer; Biochemotherapy; Fluorouracil; Folinic acid; Interleukin 2; Thymopentin
|
Indexed keywords
FLUOROURACIL;
FOLINIC ACID;
INTERLEUKIN 2;
THYMOPENTIN;
ADULT;
AGED;
ANEMIA;
ARTICLE;
CARDIOTOXICITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
FEMALE;
HUMAN;
HYPOTENSION;
INFLUENZA;
INJECTION PAIN;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
MALE;
METASTASIS;
MUCOSA INFLAMMATION;
NEPHROTOXICITY;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SKIN TOXICITY;
SUBCUTANEOUS DRUG ADMINISTRATION;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COLORECTAL NEOPLASMS;
FEMALE;
FLUOROURACIL;
HUMANS;
INTERFERON TYPE II;
INTERLEUKIN-2;
LEUCOVORIN;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
RECEPTORS, INTERLEUKIN-2;
T-LYMPHOCYTE SUBSETS;
THYMOPENTIN;
|
EID: 0029583758
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/oxfordjournals.annonc.a059065 Document Type: Article |
Times cited : (15)
|
References (0)
|